Evidence map›Paper›PMID 37962510›Full record

ArticleReproduction & fertility2023

Local production of 17β-oestradiol in the endometrium during the implantation window: a pilot study.

L B P M Stevens Brentjens, D Obukhova, B Delvoux, J E den Hartog, B N Bui, F Mol, J P de Bruin, D Besselink, G Teklenburg, F Morgan and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Reproduction & fertility, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

L B P M Stevens BrentjensDepartment of Obstetrics and Gynaecology, Maastricht University Medical Centre+, Maastricht, The Netherlands.ORCID 0000-0001-7650-8837
D ObukhovaGROW School for Oncology and Reproduction, Maastricht University, Universiteitssingel, Maastricht, The Netherlands.
B DelvouxDepartment of Obstetrics and Gynaecology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
J E den HartogDepartment of Obstetrics and Gynaecology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
B N BuiDepartment of Gynaecology & Reproductive Medicine, University Medical Centre Utrecht, Heidelberglaan, Utrecht, The Netherlands.
F MolCentre for Reproductive Medicine, Reproduction and Development, Amsterdam University Medical Centre, University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands.
J P de BruinDepartment of Obstetrics and Gynaecology, Jeroen Bosch Hospital, Henri Dunantstraat, Hertogenbosch, The Netherlands.
D BesselinkDepartment of Obstetrics and Gynaecology, Radboud University Medical Centre, Geert Grooteplein Zuid, Nijmegen, The Netherlands.
G TeklenburgIsala Fertility Clinic, Isala Hospital, Dokter van Heesweg, Zwolle, The Netherlands.
F MorganDepartment of Complex Tissue Regeneration, MERLN Institute, Maastricht University, Maastricht, The Netherlands.
M BakerDepartment of Complex Tissue Regeneration, MERLN Institute, Maastricht University, Maastricht, The Netherlands.
F J M BroekmansDepartment of Gynaecology & Reproductive Medicine, University Medical Centre Utrecht, Heidelberglaan, Utrecht, The Netherlands.
R J T van GoldeDepartment of Obstetrics and Gynaecology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
M Zamani EstekiGROW School for Oncology and Reproduction, Maastricht University, Universiteitssingel, Maastricht, The Netherlands.
A RomanoDepartment of Obstetrics and Gynaecology, Maastricht University Medical Centre+, Maastricht, The Netherlands.ORCID 0000-0002-5900-6883
Maastricht University Medical Centre · NLMaastricht University · NLUniversity Medical Center Utrecht · NLIsala · NLJeroen Bosch Ziekenhuis · NLRadboud University Nijmegen · NLUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abstract: Sex steroids are converted to bioactive metabolites and vice versa by endometrial steroid-metabolising enzymes. Studies indicate that alterations in this metabolism might affect endometrial receptivity. This pilot study determined whether the endometrial formation and inactivation of 17β-oestradiol differed between the supposedly embryo-receptive endometrium and non-receptive endometrium of women undergoing IVF/intracytoplasmic sperm injection (ICSI). Endometrial biopsies were obtained from IVF/ICSI patients 5-8 days after ovulation in a natural cycle, prior to their second IVF/ICSI cycle with fresh embryo transfer (ET). Endometrial biopsies from patients who achieved clinical pregnancy after fresh ET (n = 15) were compared with endometrial biopsies from patients that did not conceive after fresh ET (n = 15). Formation of 17β-oestradiol (oxidative 17β-hydroxysteroid dehydrogenases (HSDs)), oestrone (reductive HSD17Bs) and inhibition of HSD17B1 activity were determined by high-performance liquid chromatography. The endometrial transcriptome was profiled using RNA sequencing followed by principal component analysis and differentially expressed gene analysis. The false discovery rate-adjusted P < 0.05 and log fold change >0.5 were selected as the screening threshold. Formation and inactivation of 17β-oestradiol resulted similar between groups. Inhibition of HSD17B1 activity was significantly higher in the non-pregnant group when only primary infertile women (n = 12) were considered (27.1%, n = 5 vs 16.2%, n = 7, P = 0.04). Gene expression analysis confirmed the presence of HSD17B1 (encoding HSD17B1), HSD17B2 (encoding HSD17B2) and 33 of 46 analysed steroid metabolising enzymes in the endometrium. In the primary infertile subgroup (n = 10) 12 DEGs were found including LINC02349 which has been linked to implantation. However, the exact relationship between steroid-metabolising enzyme activity, expression and implantation outcome requires further investigation in larger, well-defined patient groups. Lay summary: Sex hormones are produced and broken down by enzymes that can be found in the endometrium (the inner lining of the womb). This enzyme activity might influence the chances of becoming pregnant. We compared (i) enzyme activity in the endometrium of 15 women who did and 15 women who did not become pregnant in their second in vitro fertilisation attempt, (ii) how enzyme activity can be blocked by an inhibitor, and (iii) differences in gene expression (the process by which instructions in our DNA are converted into a product). Enzyme activity was similar between groups. We found that in women who have never been pregnant in the past, inhibition of enzyme activity was higher and found differences in a gene that has been linked to the implantation of the embryo, but future studies should be performed in larger, well-defined patient groups to confirm these findings.

Indexed as

Infertility, FemaleAnimalsEndometriumEstradiolFemaleMalePilot ProjectsPregnancySemenEstradiolendometriumHSD17B1implantationIVFoestrogenreceptivity

Identifiers

PMID37962510
PMCPMC10762592
OpenAlexW4388654817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.